S-adenosyl-l-methionine antidepressant-like effects involve activation of 5-HT1A receptors

Detalhes bibliográficos
Autor(a) principal: Sales, Amanda J.
Data de Publicação: 2023
Outros Autores: Maciel, Izaque S., Crestani, Carlos C. [UNESP], Guimarães, Francisco S., Joca, Sâmia RL.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1016/j.neuint.2022.105442
http://hdl.handle.net/11449/246387
Resumo: S-adenosyl-l-methionine (SAMe), a methyl donor, induces antidepressant effects in preclinical and clinical studies of depression. However, the mechanisms behind these effects have been poorly investigated. Since SAMe is involved in monoamine metabolism, this work aimed at 1) testing the effects induced by systemic treatment with SAMe in mice submitted to the forced swimming test (FST) and tail suspension test (TST); 2) investigating the involvement of serotonergic neurotransmission in the behavioral effects induced by SAMe. To do that, male Swiss mice received systemic injections (1 injection/day, 1 or 7 days) of imipramine (30 mg/kg), L-methionine (400, 800, 1600, and 3200 mg/kg), SAMe (10, 25, 50, 100, and 200 mg/kg), or vehicle (10 ml/kg) and were submitted to the FST or TST, 30 min after the last injection. The effect of SAMe (50 mg/kg) was further investigated in independent groups of male Swiss mice pretreated with p-chlorophenylalanine (PCPA, serotonin synthesis inhibitor, 150 mg/kg daily, 4 days) or with WAY100635 (5-HT1A receptor antagonist, 0.1 mg/kg, 1 injection). One independent group was submitted to the FST and euthanized immediately after for collection of brain samples for neurochemical analyses. Serotonin (5-HT) and noradrenaline (NA) levels were measured in the hippocampus (HPC) and prefrontal cortex (PFC). Furthermore, to investigate if the treatments used could induce any significant exploratory/motor effect which would interfere with the FST results, the animals were also submitted to the open field test (OFT). The administration of imipramine (30 mg/kg), L-methionine (400, 800, 1600, and 3200 mg/kg), and SAMe (10 and 50 mg/kg) reduced the immobility time in the FST, an effect blocked by pretreatment with PCPA and WAY100635. None of the treatments increased the locomotion in the OFT. In conclusion, our results suggest that the antidepressant-like effects induced by SAMe treatment are dependent on serotonin synthesis and 5-HT1A receptor activation.
id UNSP_01031290c9ccae1573250195563588f3
oai_identifier_str oai:repositorio.unesp.br:11449/246387
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling S-adenosyl-l-methionine antidepressant-like effects involve activation of 5-HT1A receptors5-HT5-HT1ADepressionS-adenosyl-l-methionineSAMeSerotoninStressS-adenosyl-l-methionine (SAMe), a methyl donor, induces antidepressant effects in preclinical and clinical studies of depression. However, the mechanisms behind these effects have been poorly investigated. Since SAMe is involved in monoamine metabolism, this work aimed at 1) testing the effects induced by systemic treatment with SAMe in mice submitted to the forced swimming test (FST) and tail suspension test (TST); 2) investigating the involvement of serotonergic neurotransmission in the behavioral effects induced by SAMe. To do that, male Swiss mice received systemic injections (1 injection/day, 1 or 7 days) of imipramine (30 mg/kg), L-methionine (400, 800, 1600, and 3200 mg/kg), SAMe (10, 25, 50, 100, and 200 mg/kg), or vehicle (10 ml/kg) and were submitted to the FST or TST, 30 min after the last injection. The effect of SAMe (50 mg/kg) was further investigated in independent groups of male Swiss mice pretreated with p-chlorophenylalanine (PCPA, serotonin synthesis inhibitor, 150 mg/kg daily, 4 days) or with WAY100635 (5-HT1A receptor antagonist, 0.1 mg/kg, 1 injection). One independent group was submitted to the FST and euthanized immediately after for collection of brain samples for neurochemical analyses. Serotonin (5-HT) and noradrenaline (NA) levels were measured in the hippocampus (HPC) and prefrontal cortex (PFC). Furthermore, to investigate if the treatments used could induce any significant exploratory/motor effect which would interfere with the FST results, the animals were also submitted to the open field test (OFT). The administration of imipramine (30 mg/kg), L-methionine (400, 800, 1600, and 3200 mg/kg), and SAMe (10 and 50 mg/kg) reduced the immobility time in the FST, an effect blocked by pretreatment with PCPA and WAY100635. None of the treatments increased the locomotion in the OFT. In conclusion, our results suggest that the antidepressant-like effects induced by SAMe treatment are dependent on serotonin synthesis and 5-HT1A receptor activation.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Department of Pharmacology School of Medicine of Ribeirão Preto University of São Paulo (USP), Ribeirão Preto-SPLaboratory of Pharmacology School of Pharmaceutical Sciences of Araraquara São Paulo State University (UNESP), Araraquara-SPCenter for Interdisciplinary Research on Applied Neurosciences (NAPNA) University of São Paulo (USP)Department of Biomolecular Sciences School of Pharmaceutical Sciences of Ribeirão Preto University of São Paulo (USP), Ribeirão Preto-SPDepartment of Biomedicine Aarhus UniversityLaboratory of Pharmacology School of Pharmaceutical Sciences of Araraquara São Paulo State University (UNESP), Araraquara-SPFAPESP: 2015/01955–9 2018/15896–3Universidade de São Paulo (USP)Universidade Estadual Paulista (UNESP)Aarhus UniversitySales, Amanda J.Maciel, Izaque S.Crestani, Carlos C. [UNESP]Guimarães, Francisco S.Joca, Sâmia RL.2023-07-29T12:39:31Z2023-07-29T12:39:31Z2023-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://dx.doi.org/10.1016/j.neuint.2022.105442Neurochemistry International, v. 162.1872-97540197-0186http://hdl.handle.net/11449/24638710.1016/j.neuint.2022.1054422-s2.0-85142770155Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengNeurochemistry Internationalinfo:eu-repo/semantics/openAccess2023-07-29T12:39:31Zoai:repositorio.unesp.br:11449/246387Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T18:23:37.998672Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv S-adenosyl-l-methionine antidepressant-like effects involve activation of 5-HT1A receptors
title S-adenosyl-l-methionine antidepressant-like effects involve activation of 5-HT1A receptors
spellingShingle S-adenosyl-l-methionine antidepressant-like effects involve activation of 5-HT1A receptors
Sales, Amanda J.
5-HT
5-HT1A
Depression
S-adenosyl-l-methionine
SAMe
Serotonin
Stress
title_short S-adenosyl-l-methionine antidepressant-like effects involve activation of 5-HT1A receptors
title_full S-adenosyl-l-methionine antidepressant-like effects involve activation of 5-HT1A receptors
title_fullStr S-adenosyl-l-methionine antidepressant-like effects involve activation of 5-HT1A receptors
title_full_unstemmed S-adenosyl-l-methionine antidepressant-like effects involve activation of 5-HT1A receptors
title_sort S-adenosyl-l-methionine antidepressant-like effects involve activation of 5-HT1A receptors
author Sales, Amanda J.
author_facet Sales, Amanda J.
Maciel, Izaque S.
Crestani, Carlos C. [UNESP]
Guimarães, Francisco S.
Joca, Sâmia RL.
author_role author
author2 Maciel, Izaque S.
Crestani, Carlos C. [UNESP]
Guimarães, Francisco S.
Joca, Sâmia RL.
author2_role author
author
author
author
dc.contributor.none.fl_str_mv Universidade de São Paulo (USP)
Universidade Estadual Paulista (UNESP)
Aarhus University
dc.contributor.author.fl_str_mv Sales, Amanda J.
Maciel, Izaque S.
Crestani, Carlos C. [UNESP]
Guimarães, Francisco S.
Joca, Sâmia RL.
dc.subject.por.fl_str_mv 5-HT
5-HT1A
Depression
S-adenosyl-l-methionine
SAMe
Serotonin
Stress
topic 5-HT
5-HT1A
Depression
S-adenosyl-l-methionine
SAMe
Serotonin
Stress
description S-adenosyl-l-methionine (SAMe), a methyl donor, induces antidepressant effects in preclinical and clinical studies of depression. However, the mechanisms behind these effects have been poorly investigated. Since SAMe is involved in monoamine metabolism, this work aimed at 1) testing the effects induced by systemic treatment with SAMe in mice submitted to the forced swimming test (FST) and tail suspension test (TST); 2) investigating the involvement of serotonergic neurotransmission in the behavioral effects induced by SAMe. To do that, male Swiss mice received systemic injections (1 injection/day, 1 or 7 days) of imipramine (30 mg/kg), L-methionine (400, 800, 1600, and 3200 mg/kg), SAMe (10, 25, 50, 100, and 200 mg/kg), or vehicle (10 ml/kg) and were submitted to the FST or TST, 30 min after the last injection. The effect of SAMe (50 mg/kg) was further investigated in independent groups of male Swiss mice pretreated with p-chlorophenylalanine (PCPA, serotonin synthesis inhibitor, 150 mg/kg daily, 4 days) or with WAY100635 (5-HT1A receptor antagonist, 0.1 mg/kg, 1 injection). One independent group was submitted to the FST and euthanized immediately after for collection of brain samples for neurochemical analyses. Serotonin (5-HT) and noradrenaline (NA) levels were measured in the hippocampus (HPC) and prefrontal cortex (PFC). Furthermore, to investigate if the treatments used could induce any significant exploratory/motor effect which would interfere with the FST results, the animals were also submitted to the open field test (OFT). The administration of imipramine (30 mg/kg), L-methionine (400, 800, 1600, and 3200 mg/kg), and SAMe (10 and 50 mg/kg) reduced the immobility time in the FST, an effect blocked by pretreatment with PCPA and WAY100635. None of the treatments increased the locomotion in the OFT. In conclusion, our results suggest that the antidepressant-like effects induced by SAMe treatment are dependent on serotonin synthesis and 5-HT1A receptor activation.
publishDate 2023
dc.date.none.fl_str_mv 2023-07-29T12:39:31Z
2023-07-29T12:39:31Z
2023-01-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1016/j.neuint.2022.105442
Neurochemistry International, v. 162.
1872-9754
0197-0186
http://hdl.handle.net/11449/246387
10.1016/j.neuint.2022.105442
2-s2.0-85142770155
url http://dx.doi.org/10.1016/j.neuint.2022.105442
http://hdl.handle.net/11449/246387
identifier_str_mv Neurochemistry International, v. 162.
1872-9754
0197-0186
10.1016/j.neuint.2022.105442
2-s2.0-85142770155
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Neurochemistry International
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1808128926326718464